Hengrui Medicine (01276.HK) spent approximately 14.8799 million Hong Kong dollars on November 21 to repurchase 250,000 shares.

Cnstock news APP reported that Hansoh Pharmaceutical (01276.HK) announced the repurchase of 250,000 shares for approximately 14.8799 million Hong Kong dollars on November 21, 2025.